Rocket Lab stock drops nearly 10% as Neutron timing stays in focus ahead of Feb. 26 results

Rocket Lab stock drops nearly 10% as Neutron timing stays in focus ahead of Feb. 26 results

New York, Jan 26, 2026, 19:41 EST — After-hours

  • Rocket Lab shares fell 9.5% by the close, then inched up during after-hours trading
  • Company scheduled to report fourth-quarter and full-year 2025 results on Feb. 26, following the U.S. market close
  • Rocket Lab reported a schedule update for the February Neutron launch following a rupture during a Stage 1 tank test

Shares of Rocket Lab Corporation plunged 9.5% to close at $80.45 on Monday. In after-hours trading, the stock clawed back slightly, rising about 0.5% to $80.84. 1

Rocket Lab’s stock jumped around this week as investors pressed for clearer timelines on Neutron, the company’s upcoming rocket designed for heavier payloads. Two after-hours updates provided fresh dates — though not the definitive schedule many hoped for. 1

Rocket Lab announced Monday that it will release its fourth-quarter and full-year 2025 financial results after U.S. markets close on Feb. 26. The company also scheduled a conference call for 5 p.m. Eastern. 2

Separately, Rocket Lab announced that the “Hungry Hippo” captive fairing for Neutron has reached Wallops Island, Virginia. It will now undergo inspections before moving on to more pre-launch tests near Launch Complex 3. The payload fairing, which protects the spacecraft during ascent, is unique for Neutron—it stays attached throughout the mission and return. 3

Neutron’s progress has sparked volatility since Rocket Lab revealed in an SEC filing last week that a Stage 1 tank burst during a hydrostatic pressure test, which stresses the tank to verify its strength. The company is now analyzing the data to understand how this might affect Neutron’s launch timeline. 4

The company confirmed that production of the next Stage 1 tank is underway and intends to provide an update on Neutron’s timeline during its February earnings call. 5

Rocket Lab’s shares fluctuated from $80.01 up to $87.16 on Monday, as over 21 million shares exchanged hands, data from Stock Analysis shows. 1

Neutron aims to be a reusable, medium-lift rocket—a field currently led by SpaceX’s Falcon 9. Rocket Lab markets it as a bigger step beyond its smaller Electron launcher, targeting more substantial government and commercial missions. 6

The downside is clear: any delays in Neutron’s test flights could push back its first launch, prompting investors to slash near-term growth forecasts as the company keeps burning cash on development. 5

Rocket Lab will report earnings after the close on Feb. 26, followed by a conference call at 5 p.m. Eastern. The company has indicated it will use that call to provide its latest update on the Neutron schedule. 2

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Texas Instruments stock price holds near $197 after-hours as TXN earnings loom
Previous Story

Texas Instruments stock price holds near $197 after-hours as TXN earnings loom

Seagate stock price jumps after hours ahead of Q2 earnings as demand signals loom
Next Story

Seagate stock price jumps after hours ahead of Q2 earnings as demand signals loom

Go toTop